Adriana Buskin,Lili Zhu,Valeria Chichagova,Basudha Basu,Sina Mozaffari-Jovin,David Dolan,Alastair Droop,Joseph Collin,Revital Bronstein,Sudeep Mehrotra,Michael Farkas,Gerrit Hilgen,Kathryn White,Dean Hallam,Katarzyna Bialas,Git Chung,Carla Mellough,Yuchun Ding,Natalio Krasnogor,Stefan Przyborski,Jumana Al-Aama,Sameer Alharthi,Yaobo Xu,Gabrielle Wheway,Katarzyna Szymanska,Martin McKibbin,Chris F Inglehearn,David J Elliott,Susan Lindsay,Robin R Ali,David H Steel,Lyle Armstrong,Evelyne Sernagor,Eric Pierce,Reinhard Lüehrmann,Sushma-Nagaraja Grellscheid,Colin A Johnson,Majlinda Lako

Abstract:Summary Mutations in pre-mRNA processing factors (PRPFs) cause 40% of autosomal dominant retinitis pigmentosa (RP), but it is unclear why mutations in ubiquitously expressed PRPFs cause retinal disease. To understand the molecular basis of this phenotype, we have generated RP type 11 (PRPF31- mutated) patient-specific retinal organoids and retinal pigment epithelium (RPE) from induced pluripotent stem cells (iPSC). Impaired alternative splicing of genes encoding pre-mRNA splicing proteins occurred in patient-specific retinal cells and Prpf31 +/− mouse retinae, but not fibroblasts and iPSCs, providing mechanistic insights into retinal-specific phenotypes of PRPFs. RPE was the most affected, characterised by loss of apical-basal polarity, reduced trans-epithelial resistance, phagocytic capacity, microvilli, and cilia length and incidence. Disrupted cilia morphology was observed in patient-derived-photoreceptors that displayed progressive features associated with degeneration and cell stress. In situ gene-editing of a pathogenic mutation rescued key structural and functional phenotypes in RPE and photoreceptors, providing proof-of-concept for future therapeutic strategies. eTOC PRPF31 is a ubiquitously expressed pre-mRNA processing factor that when mutated causes autosomal dominant RP. Using a patient-specific iPSC approach, Buskin and Zhu et al. show that retinal-specific defects result from altered splicing of genes involved in the splicing process itself, leading to impaired splicing, loss of RPE polarity and diminished phagocytic ability as well as reduced cilia incidence and length in both photoreceptors and RPE. Highlights Successful generation of iPSC-derived RPE and photoreceptors from four RP type 11 patients RPE cells express the mutant PRPF31 protein and show the lowest expression of wildtype protein PRPF31 mutations result in altered splicing of genes involved in pre-mRNA splicing in RPE and retinal organoids Prpf31 haploinsufficiency results in altered splicing of genes involved in pre-mRNA splicing in mouse retina RPE cells display loss of polarity, reduced barrier function and phagocytosis Photoreceptors display shorter and fewer cilia and degenerative features RPE cells display most abnormalities suggesting they might be the primary site of pathogenesis In situ gene editing corrects the mutation and rescues key phenotypes

CRISPR/Cas9-mediated Generation of a Human Induced Pluripotent Stem Cell Line with PRPF6 C.2699 G > A Mutation to Model Retinitis Pigmentosa

Aberrant Retinal Pigment Epithelial Cells Derived from Induced Pluripotent Stem Cells of a Retinitis Pigmentosa Patient with the PRPF6 Mutation

Generation of a gene-corrected isogenic human iPSC line (CSUASOi006-A-1) from a retinitis pigmentosa patient with heterozygous c.5792C > T mutation in the PRPF8 gene

Generation of an induced pluripotent stem cell line (SJTUGHi001-A) from a patient with Retinitis Pigmentosa carrying c.77C > T mutation in RAX2 gene

Generation of the human iPSC line ESi132-A from a patient with retinitis pigmentosa caused by a mutation in the PRPF31 gene

Establishment of the induced pluripotent stem cell line SJTUGHi002-A from a CNGA1-related recessive retinitis pigmentosa patient

Generation of the induced pluripotent stem cell line IOCVi001-A from a patient with the MFRP -related retinitis pigmentosa-nanophthalmos syndrome

Human iPSC-derived RPE and retinal organoids reveal impaired alternative splicing of genes involved in pre-mRNA splicing in PRPF31 autosomal dominant retinitis pigmentosa

Introduction of an RS1 mutation causative variant consistent with identified XLRS patient using CRISPR/Cas9 technology in normal iPSC

Mutant PRPF8 Causes Widespread Splicing Changes in Spliceosome Components in Retinitis Pigmentosa Patient iPSC-Derived RPE Cells

Modeling PRPF31 retinitis pigmentosa using retinal pigment epithelium and organoids combined with gene augmentation rescue

Generation of human induced pluripotent stem cell lines from a subject with UBAP1L-associated retinal dystrophy and CRISPR/cas9-corrected isogenic iPSC lines

Pre-mRNA Processing Factors and Retinitis Pigmentosa: RNA Splicing and Beyond

Restoration of RPGR expression in vivo using CRISPR/Cas9 gene editing

Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa

Mutant Prpf31 causes pre-mRNA splicing defects and rod photoreceptor cell degeneration in a zebrafish model for Retinitis pigmentosa

Gene augmentation prevents retinal degeneration in a CRISPR/Cas9-based mouse model of PRPF31 retinitis pigmentosa

Identification of a PRPF4 loss-of-function variant that abrogates U4/U6.U5 tri-snRNP integration and is associated with retinitis pigmentosa

Allele-Specific Knockout by CRISPR/Cas to Treat Autosomal Dominant Retinitis Pigmentosa Caused by the G56R Mutation in NR2E3

Modeling autosomal dominant retinitis pigmentosa by using patient-specific retinal organoids with a class-3 RHO mutation

Novel Mutations In Pde6b Causing Human Retinitis Pigmentosa